TABLE 1.
Sensitivity EC50 |
Response time t½ |
Steady-state level |
Total abundance of corresponding protein in T2D | Refs. | ||||
---|---|---|---|---|---|---|---|---|
contr | T2D | contr | T2D | contr | T2D | |||
nm insulin | min | -fold over basal contr | % of contr | |||||
IR-Tyr(P) | 1.0 | 1.0 | 1.0 | ND | 4.3 | 1.5 | 55 | 25, 31 |
IRS1-Tyr(P) | 0.3 | 2.0 | 1.0 | ND | 2.6 | 1.0 | ns | 23, 25, 31 |
IRS1-Ser(P)307 | 0.2 | 0.9 | 0.7 | 2.0 | 4.4 | 1.9 | 25 | |
PKB-Thr(P)308 | 0.3 | 0.4 | ND | ND | 5.0 | 5.0 | ns | 25, herein |
PKB-Ser(P)473 | 0.1 | 0.4 | 1.0 | 1.0 | 5.0 | 5.0 | 25 | |
AS160-Thr(P)642 | 0.02 | 0.2 | 1.5 | 2.0 | 2.9 | 1.3 | 45 | 25, herein |
Glucose transport | 0.04 | 0.2 | ND | ND | 2.1 | 1.0 | 50 | 25 |
S6K1-Thr(P)389 | ND | ND | 7.5 | 7.5 | 4.1 | 2.6 | ns | 24, 25 |
S6-Ser(P)235/236 | 0.3 | ND | 15 | 4.3 | 2.5 | 48 | 25, herein | |
ERK1/2-Thr(P)202/Tyr(P)204 | 0.2 | 0.7 | 2.5 | 2.5 | no-ss | no-ss | ns | 26 |
Elk1-Ser(P)383 | ND | ND | 5 | no-ss | no-ss | ns | 26 | |
FOXO1-Ser(P)256 | 0.02 | 0.02 | 5 | 5 | 1.7 | 1.1 | 55 | Herein |